DIFFERENTIAL TRANSPORT OF PRAVASTATIN AND LOVASTATIN BY HEPATOCYTES AND FIBROBLASTS

被引：0
|
作者：
MAHONEY, EM [1 ]
CHILD, MJ [1 ]
SMITHMONROY, CA [1 ]
机构：
[1] BRISTOL MYERS SQUIBB,PRINCETON,NJ
来源：
CIRCULATION | 1990年 / 82卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：6 / 6
页数：1
相关论文
共 50 条
  • [41] Development and Validation of a Simple and Fast HPLC Method for Determination of Lovastatin, Pravastatin and Simvastatin
    Silva, Taizia D.
    Oliveira, Marcelo A.
    de Oliveira, Renata B.
    Vianna-Soares, Cristina D.
    JOURNAL OF CHROMATOGRAPHIC SCIENCE, 2012, 50 (09) : 831 - 838
  • [42] Impact of therapeutic interchange from pravastatin to lovastatin in a veterans affairs medical center
    Patel, RJ
    Gray, DR
    Pierce, R
    Jafari, M
    AMERICAN JOURNAL OF MANAGED CARE, 1999, 5 (04): : 465 - 474
  • [43] Differential mitochondrial bioenergetics and cellular resilience in astrocytes, hepatocytes, and fibroblasts from aging baboons
    Adekunbi, Daniel A.
    Huber, Hillary F.
    Li, Cun
    Nathanielsz, Peter W.
    Cox, Laura A.
    Salmon, Adam B.
    GEROSCIENCE, 2024, 46 (5) : 4443 - 4459
  • [44] Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin
    Neuvonen, Pertti J.
    Backman, Janne T.
    Niemi, Mikko
    CLINICAL PHARMACOKINETICS, 2008, 47 (07) : 463 - 474
  • [45] Cyclosporine drug interactions with the metabolism of the HMG-COA reductase inhibitors lovastatin and pravastatin
    Christians, U
    Jacobsen, W
    Kirchner, G
    Mancinelli, L
    Hackbarth, I
    Mangold, B
    Sewing, KF
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (04) : R158 - R158
  • [46] Effects of Lovastatin and Pravastatin on Amyloid Processing and Inflammatory Response in TgCRND8 Brain
    Neelima B. Chauhan
    George J. Siegel
    Douglas L. Feinstein
    Neurochemical Research, 2004, 29 : 1897 - 1911
  • [47] PHARMACOKINETIC INTERACTION BETWEEN PROPRANOLOL AND THE HMG-COA REDUCTASE INHIBITORS PRAVASTATIN AND LOVASTATIN
    PAN, HY
    TRISCARI, J
    DEVAULT, AR
    SMITH, SA
    WANGIVERSON, D
    SWANSON, BN
    WILLARD, DA
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (06) : 665 - 670
  • [48] COMPARISON OF THE SHORT-TERM EFFICACY AND TOLERABILITY OF LOVASTATIN AND PRAVASTATIN IN THE MANAGEMENT OF PRIMARY HYPERCHOLESTEROLEMIA
    MCPHERSON, R
    BEDARD, J
    CONNELLY, P
    CURNEW, G
    DAVIGNON, J
    ECHENBERG, D
    LAVIN, P
    LEITER, L
    LENIS, J
    MCQUEEN, M
    MONTIGNY, M
    MUNOZ, C
    OLEARY, T
    OOI, T
    ROULEAU, JL
    SPENCE, D
    TAN, M
    THEROUX, P
    CLINICAL THERAPEUTICS, 1992, 14 (02) : 276 - 291
  • [49] TISSUE SELECTIVITY OF THE CHOLESTEROL-LOWERING AGENTS LOVASTATIN, SIMVASTATIN AND PRAVASTATIN IN RATS INVIVO
    GERMERSHAUSEN, JI
    HUNT, VM
    BOSTEDOR, RG
    BAILEY, PJ
    KARKAS, JD
    ALBERTS, AW
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 158 (03) : 667 - 675
  • [50] No clinically relevant changes in the exposure of lovastatin or pravastatin with concurrent administration of LY518674.
    Farid, N. A.
    Harris, C. J.
    Abu-Raddad, E.
    Wang, M.
    Howey, D. C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S112 - S112
12345